Cargando…

1581. Impact of Colonization with Fluoroquinolone-Resistant Enterobacteriaceae on the Risk of Gram-Negative Bacteremia in Hematopoietic Stem Cell Transplant Recipients Who Receive Prophylactic Levofloxacin

BACKGROUND: Fluoroquinolone (FQ) prophylaxis is widely used to prevent bloodstream infections (BSIs) in neutropenic patients undergoing hematopoietic stem cell transplantation (HCT). In order to assess whether increasing FQ resistance threatens the effectiveness of FQ prophylaxis, we screened HCT re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Satlin, Michael J, Douglass, Claire, Hovan, Michael, Soave, Rosemary, Chan, Anna, Shore, Tsiporah B, Besien, Koen Van, Mayer, Sebastian, Phillips, Adrienne A, Hsu, Jing-Mei, Malherbe, Rianna, Jenkins, Stephen G, Kreiswirth, Barry N, Westblade, Lars F, Walsh, Thomas J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252824/ http://dx.doi.org/10.1093/ofid/ofy210.1409

Ejemplares similares

Comparison of Perianal Swab and Stool Samples for Detection of Gastrointestinal Colonization with Ceftriaxone-Resistant and Fluoroquinolone-Resistant Enterobacteriaceae
por: Satlin, Michael, et al.
Publicado: (2017)

Incidence, significance, and persistence of human coronavirus infection in hematopoietic stem cell transplant recipients
por: Eichenberger, Emily M., et al.
Publicado: (2018)

2501. Impact of Influenza A and B Infection on Stem Cell Transplant Patients During the 2017–2018 Season at a Single Center
por: Pyai, Khin Sandar, et al.
Publicado: (2018)

Coronavirus Infection in Hematopoietic Stem Cell Transplant Recipients
por: Eichenberger, Emily, et al.
Publicado: (2017)

2695. Pneumocystis jirovecii Pneumonia in the Era of Effective Prophylaxis Following Hematopoietic Stem Cell Transplant
por: Drelick, Alexander Christian, et al.
Publicado: (2019)

1826. Impact of Rapid Diagnostics and Ceftazidime–Avibactam on Mortality after Bacteremia Caused by Carbapenem-Resistant Enterobacteriaceae
por: Satlin, Michael J, et al.
Publicado: (2019)

1589. Increased Detection of Diarrheal Pathogens in Hematopoietic Stem Cell Transplant Recipients Using a Multiplexed PCR Panel
por: Rogers, Wesley, et al.
Publicado: (2018)

Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell–Depleted Stem Cell Transplantation
por: Chaekal, Ok-kyong, et al.
Publicado: (2022)

Trends in Fluoroquinolone (Ciprofloxacin) Resistance in Enterobacteriaceae from Bacteremias, England and Wales, 1990–1999
por: Livermore, David M., et al.
Publicado: (2002)

1072. Streamlining to Oral β-Lactam vs. Fluoroquinolone as Definitive Therapy for Enterobacteriaceae Bacteremia
por: Fong, Karen, et al.
Publicado: (2018)

1885. Cost-Effectiveness of Ceftazidime–Avibactam Compared With Colistin for Treatment of Carbapenem-Resistant Enterobacteriaceae Bacteremia and Pneumonia
por: Sfeir, Maroun, et al.
Publicado: (2018)

1581. Comparative In Vitro Activity of Ceftolozane/tazobactam and Comparator Agents Against Enterobacteriaceae and Pseudomonas Aeruginosa Clinical Isolates in Colombia
por: Hernández-Gómez, Cristhian, et al.
Publicado: (2019)

532. COVID-19 Pneumonia in Patients with Hematologic Malignancies – A Report from the US Epicenter
por: Plate, Markus, et al.
Publicado: (2020)

124. Impact of Levofloxacin MIC on Outcomes with Levofloxacin Step-down Therapy in Enterobacteriaceae Bloodstream Infections
por: White, Melissa, et al.
Publicado: (2019)

Biotransformation of the Fluoroquinolone, Levofloxacin, by the White-Rot Fungus Coriolopsis gallica
por: Ben Ayed, Amal, et al.
Publicado: (2022)

1599. Clinical Outcomes for Patients Treated with Fluoroquinolones for Bacteremia Caused by Enterobacteriaceae Reclassified as Not Susceptible by Updated CLSI Breakpoints
por: Fleischner, Zachary, et al.
Publicado: (2020)

Bacteremia due to Carbapenem-Resistant Enterobacteriaceae (CRE) in New York and New Jersey: A Clinical and Molecular Epidemiologic Analysis
por: Satlin, Michael, et al.
Publicado: (2015)

434 Prevalence, Risk Factors, and Outcomes of Bacteremia Caused by Carbapenem-resistant Enterobacteriaceae in Neutropenic Patients with Hematologic Malignancies
por: Satlin, Michael J., et al.
Publicado: (2014)

Prophylactic intracameral levofloxacin in cataract surgery – an evaluation of safety
por: Espiritu, Cesar Ramon G, et al.
Publicado: (2017)

Clinical and molecular epidemiology of human rhinovirus infections in patients with hematologic malignancy
por: Jacobs, Samantha E., et al.
Publicado: (2015)

Oral Fluoroquinolone or Trimethoprim-Sulfamethoxazole vs ß-Lactams as Step-Down Therapy for Enterobacteriaceae Bacteremia: Systematic Review and Meta-analysis
por: Punjabi, Chitra, et al.
Publicado: (2019)

1581O Estimation of European cancer burden for the year 2020
por: Dyba, T.A., et al.
Publicado: (2020)

Effects of the Fluoroquinolones Moxifloxacin and Levofloxacin on the QT Subintervals: Sex Differences in Ventricular Repolarization
por: Täubel, Jӧrg, et al.
Publicado: (2019)

Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan–Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation
por: Patel, Khilna, et al.
Publicado: (2016)

Treatment of Listeria monocytogenes bacteremia with oral levofloxacin in an immunocompromised patient
por: Ishihara, Yo, et al.
Publicado: (2023)

Gut commensal microbiota and decreased risk for Enterobacteriaceae bacteriuria and urinary tract infection
por: Magruder, Matthew, et al.
Publicado: (2020)

Pleiotropic Effects of Levofloxacin, Fluoroquinolone Antibiotics, against Influenza Virus-Induced Lung Injury
por: Enoki, Yuki, et al.
Publicado: (2015)

Could Respiratory Fluoroquinolones, Levofloxacin and Moxifloxacin, Prove to be Beneficial as an Adjunct Treatment in COVID-19?
por: Karampela, Irene, et al.
Publicado: (2020)

959 Epidemiology and Treatment of Enterobacteriaceae Bacteremia: Combination vs Monotherapy
por: Berkowitz, Nina, et al.
Publicado: (2014)

Relaciones y memorias de la provincia de Michoacán, 1579-1581
Publicado: (1985)

1581 Laboratory Evaluation of three HIV and Syphilis Combination Rapid Diagnostic Tests
por: Humphries, Romney M., et al.
Publicado: (2014)

304. Predictors of mortality in carbapenem-resistant Enterobacteriales bacteremia
por: Hovan, Michael R, et al.
Publicado: (2020)

191. Appropriateness of Empiric Antibiotics for Enterobacteriaceae Bacteremia
por: Smith, Brandon J, et al.
Publicado: (2019)

Characterization of fluoroquinolone resistance and qnr diversity in Enterobacteriaceae from municipal biosolids
por: Kaplan, Ella, et al.
Publicado: (2013)

Construction, expression, and characterization of AG1(1–843) and AG1(1–1581)
por: Yan, Xie, et al.
Publicado: (2018)

P1581: FEEDING IMMUNITY‘S CLOCK. THE REGULATION OF CIRCADIAN IMMUNE RESPONSES BY NUTRITIONAL CUES.
por: Geiger, S., et al.
Publicado: (2022)

Clinical Impact of Fluoroquinolone-Resistant Escherichia coli in the Fecal Flora of Hematological Patients with Neutropenia and Levofloxacin Prophylaxis
por: Chong, Yong, et al.
Publicado: (2014)

258. A Comparison of Cefprozil and Fluoroquinolones for Gram-Negative Bacteremia
por: Nolen, Rebecca C, et al.
Publicado: (2020)

Pseudomonas aeruginosa bacteremia in patients with liver cirrhosis: a comparison with bacteremia caused by Enterobacteriaceae
por: Bang, Ji Hwan, et al.
Publicado: (2013)

Diabetes does not affect outcome in patients with Enterobacteriaceae bacteremia
por: Peralta, Galo, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_0s0bphfpb9t7e26e4am4aouml6